|Articles|July 1, 2000

July 2000
Volume 6
Issue 7

Interactive Voice Response Systems in the Diagnosis and Management of Chronic Disease

Author(s)John D. Piette, PhD

Download PDF: Interactive Voice Response Systems in the Diagnosis and Management of Chronic Disease

Articles in this issue

about 26 years ago

Article

Improving the Sensitivity of Cervical Cytology: What Are the Issues?

about 26 years ago

Article

Why Are Drug Prices Lower in Canada?

about 26 years ago

Article

Comparing the Medical Expenses of Children with Medicaid and Commercial Insurance in an HMO

about 26 years ago

Article

Clinical and Cost Implications of New Technologies for Cervical Cancer Screening: The Impact of Test Sensitivity

about 26 years ago

Article

High-Risk Population Health Management -- Achieving Improved Patient Outcomes and Near-Term Financial Results

about 26 years ago

Article

Design and Implementation of an Inpatient Disease Management Program

about 26 years ago

Article

Managing Drug Costs: The Perception of Managed Care Pharmacy Directors

about 26 years ago

Article

Mandated Managed Care for Blind and Disables Medicaid Beneficiaries in a County-Organized Health System: Implementation Challenges and Access Issues

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe

Related Content

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

ByChristopher Scannell, MD, PhD,John A. Romley, PhD,Rebecca Myerson, PhD,Dana Goldman, PhD,Dima Mazen Qato, PharmD, PhD, MPH

July 9th 2026

Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers

ByJulie A. Patterson, PharmD, PhD,Roswell A. Cole, PharmD, MPH,Jonathan D. Campbell, PhD, MS,John Michael O’Brien, PharmD, MPH

July 9th 2026

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value

ByVivian T. E. Tar, PharmD, MBA

July 8th 2026

Interactive Voice Response Systems in the Diagnosis and Management of Chronic Disease

Articles in this issue

Related Content

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value

Trending on AJMC

FDA Approves Enlicitide, First Oral PCSK9 for High Cholesterol

Home-Based Heart Failure Care Shows Comparable Safety to Continued Inpatient Care

Cardiology Prices Vary Widely by Insurer and State

Voice Biomarkers Show Promise for Asthma, COPD Exacerbation Detection

Rethinking Cardiometabolic Risk: Deepak Bhatt, MD, MPH, MBA